8th Forum on

Pharma and Biotech In-licensing, Co-development and co-promotion Agreements

Negotiating and Drafting Creative and Flexible Agreements to Maximize Profits in the U.S. and Global Pharmaceutical and Biotech Marketplaces

Monday, November 15, 2004

About

Do you have the information and skills you need to structure, negotiate, and manage complex deals that will expand your company's business, both in the U.S. and internationally?

Today, virtually all pharmaceutical companies are seeking product candidates-ranging from late-stage drugs to early discovery-stage contenders-in an effort to fill depleted product pipelines. To accomplish this goal, pharmaceutical and biotech companies are partnering with each other and research institutions through in-licensing (and out-licensing), co-development and co-promotion.

The challenge today, however, is this: how do you creatively negotiate and structure these complex, multi-layered collaborations to endure the twists and turns that occur over the long course of product discovery and development in the domestic and international marketplaces?

With the high stakes surrounding these collaborations, it is imperative that in-house counsel, senior business executives and attorneys advising the pharmaceutical and biotech industries have an up-to-the-minute and in-depth understanding of the legal and business issues surrounding today's complex in-licensing, co-development and co-promotion transactions.

American Conference Institute's 8th Forum on Pharma and Biotech In-Licensing, Co-Development and Co-Promotion Agreements will provide you with the tools you need to create sound and strategically effective agreements. An expert faculty of leading pharmaceutical and biotech in-house counsel and executives, as well as expert attorneys and investment bankers, will provide must-have insights.

Contents & Contributors

About

Do you have the information and skills you need to structure, negotiate, and manage complex deals that will expand your company's business, both in the U.S. and internationally?

Today, virtually all pharmaceutical companies are seeking product candidates-ranging from late-stage drugs to early discovery-stage contenders-in an effort to fill depleted product pipelines. To accomplish this goal, pharmaceutical and biotech companies are partnering with each other and research institutions through in-licensing (and out-licensing), co-development and co-promotion.

The challenge today, however, is this: how do you creatively negotiate and structure these complex, multi-layered collaborations to endure the twists and turns that occur over the long course of product discovery and development in the domestic and international marketplaces?

With the high stakes surrounding these collaborations, it is imperative that in-house counsel, senior business executives and attorneys advising the pharmaceutical and biotech industries have an up-to-the-minute and in-depth understanding of the legal and business issues surrounding today's complex in-licensing, co-development and co-promotion transactions.

American Conference Institute's 8th Forum on Pharma and Biotech In-Licensing, Co-Development and Co-Promotion Agreements will provide you with the tools you need to create sound and strategically effective agreements. An expert faculty of leading pharmaceutical and biotech in-house counsel and executives, as well as expert attorneys and investment bankers, will provide must-have insights.

Contents & Contributors

HOT BUTTONS IN DUE DILIGENCE AND RISK ASSESSMENT
Thomas Kowalski, Frommer Lawrence & Haug

LICENSE AS PART OF A PATENT SETTLEMENT
Karen Bokat, Wiley Rein & Fielding LLP

ANTITRUST GUIDELINES FOR THE LICENSING OF INTELLECTUAL PROPERTY
Steve Stack, Dechert LLP

CONSIDERATIONS WHEN DRAFTING INDUSTRY LICENSING AGREEMENTS
Jan Reid, Wyeth Vaccines

CONSIDERATIONS WHEN DRAFTING INDUSTRY LICENSING AGREEMENTS
Jerry Cohen, Cohen, Tauber, Spievack & Wagner LLP

STRUCTURING "WIN-WIN" IN-LICENSING AND CO-DEVELOPMENT COLLABORATIONS WITH UNIVERSITIES
Susan Galli, Ropes & Gray
Jonathan Lourie, Edwards & Angell, LLP

CO-PROMOTION COLLABORATIONS: CONSIDERATIONS AND STRATEGIES FOR A WINNING DEAL
Philip Hahn, Pfizer, Inc.

CO-PROMOTION COLLABORATIONS: CONSIDERATIONS AND STRATEGIES FOR A WINNING DEAL
Barclay Kamb, Cooley Godward LLP

HOW TO PLAY THE END GAME: THE ART AND SCIENCE OF TERMINATION
Larry Tauber, Cohen, Tauber, Spievack & Wagner LLP

TAKING YOUR UNITED STATES AGREEMENT OVERSEAS: INTERNATIONAL CONCERNS IN IN-LICENSING, CO-DEVELOPMENT, AND CO-PROMOTION AGREEMENTS
Joel Wolfson, Blank Rome LLP

EUROPEAN COLLABORATION AND LICENSE AGREEMENTS
David Hull, Covington & Burling
Colin Sainsbury, BCM Hanby Wallace Solicitors



DOCUMENT TYPES: PRESENTATIONS AVAILABLE: 0